The EXODUS H-600 offers an automated, scalable approach to exosome isolation, which should reduce hands-on processing and ...

On board the Schmidt Ocean Institute’s R/V Falkor, a Western Australian Museum-led expedition surveyed the deep Cape Range and Cloates submarine canyons, which are located around 1200 km north of ...

Lonza has launched the Nebula Absorbance Reader, an absorbance microplate reader that joins the company’s portfolio of optimised instruments for streamlined endotoxin and pyrogen testing.

A strategic partnership between Vaxxas and Profenso, an Australian artificial intelligence company specialising in advanced automation for regulated industries, has been announced. The partnership is ...

This is a video of the sod-turning for the Sydney Biomedical Accelerator (SBA), which opens in 2028. A $780 million partnership between the University of Sydney, Sydney Local Health District and the ...

Building on the reputation of MaxWell Biosystems’ high-density microelectrode arrays (HD-MEAs), the company’s next-generation electrode design is designed to advance the current technology even ...

Involving more than 150 hospitals across more than 14 countries, a global clinical trial supports a rethink of the default treatment for MSSA and PSSA infections. More than one million deaths per year ...

RMIT University has announced it is investing $30 million in health and care capability, the majority centring on health capabilities at its Bundoora campus, which will become a precinct for education ...

The Barwon Health–Deakin University Clinical Trials Alliance is intended to grow a regionally embedded but globally responsive partnership. Drawing on the complementary strengths of Barwon Health and ...

Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney Biomedical Accelerator (SBA), which opens in 2028. A $780 million partnership between the University of Sydney ...

Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology paper reveals the science behind its immune system platform and opens the door for new drugs. According to ...

UniQuest, the commercialisation company of The University of Queensland (UQ), has entered into an exclusive licence agreement with the Ellison Medical Institute (EMI) to develop and commercialise UQ’s ...